FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070411 [Registered on: 10/07/2024] Trial Registered Prospectively
Last Modified On: 02/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Single Arm Study 
Public Title of Study   To evaluate the efficacy of shatavaryadi granules with madhu and sheeta kshira in management of garbhini parikartika (fissure in ano in pregnancy  
Scientific Title of Study   Single arm clinical study to evaluate the efficacy of shatavaryadi granules with madhu and sheeta kshira in management of garbhini parikartika fissure in ano in pregnancy  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Drshubhangi Dhanraj Sonwane  
Designation  M S scholar  
Affiliation  Dr.D.Y.Patil ayurvedic medical College and research centre pimpri pune  
Address  OPD no 2, streeroga evum prasutitantra department Dr.D.Y.Patil ayurvedic medical College and research centre pimpri pune 411018

Pune
MAHARASHTRA
411018
India 
Phone  9975614480  
Fax    
Email  shubhangisonwane25@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr smritika Taware 
Designation  MD professor  
Affiliation  Dr.D.Y.Patil ayurvedic medical College and research centre pimpri pune  
Address  OPD no 2, streeroga evum prasutitantra department Dr.D.Y.Patil ayurvedic medical College and research centre pimpri pune

Pune
MAHARASHTRA
411018
India 
Phone  9850967067  
Fax    
Email  bhonsalesmritika@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Drshubhangi Dhanraj Sonwane  
Designation  M S scholar  
Affiliation  Dr.D.Y.Patil ayurvedic medical College and research centre pimpri pune  
Address  OPD no 2 streeroga evam prasutitantra,Dr.D.Y.Patil ayurvedic medical College and research centre pimpri pune 411018

Pune
MAHARASHTRA
411018
India 
Phone  9975614480  
Fax    
Email  shubhangisonwane25@gmail.com  
 
Source of Monetary or Material Support  
Dr.D.Y.Patil college of ayurved and research centre pimpri pune 411018 
 
Primary Sponsor  
Name  Drshubhangi Dhanraj Sonwane  
Address  OPD no 2, streeroga evum prasutitantra Dr.D.Y.Patil Ayurved medical College and research centre pimpri pune 411018 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrShubhangi Sonwane   Dr.D.Y.Patil college of ayurved and research centre pimpri pune 411018  OPD no 2 streeroga evum prasutitantra department Dr.D.Y.Patil college of ayurved and research centre pimpri pune 411018
Pune
MAHARASHTRA 
9975614480

shubhangisonwane25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
DR DYPCA AND RC INSTITUTIONAL ETHICS COMMITTEE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:O268||Other specified pregnancy relatedconditions. Ayurveda Condition: GARBINIROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Shatavaryadi granules with madhu and sheeta kshira , Reference: Kashaypa samhita garbhini chikitsaadhya 1/2, Route: Oral, Dosage Form: Khanda /Granules, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: Madhu,sheeta kshir), Additional Information: -
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1. Garbhini with age group of 19 to 40 years will be selected.
2. Garbhini having atleast 3 symptoms of following:
-severe constipation
- Pain during fecation
-burning sensation at anal region
-Bleeding at anal region
3.Both primigravida or multigravida In 2nd and 3rd trimister 
 
ExclusionCriteria 
Details  1. Patients having any chronic or systemic illness.
3. Patient suffering from acquired or congenital immune deficiency.
4. Patients having intussusceptions.
5. Pt having any other associated diseases like pregnancy induced
diabetes, pregnancy induced hypertension 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Effect of shatavaryadi granules with madhu and sheeta kshira in management of garbhini parikartika (fissure in ano in pregnancy) which will be assessed by the symptoms bleeding during defecation, itching over anal region, severe constipation, burning at anal region   14 days study with follow up on 7th day 
 
Secondary Outcome  
Outcome  TimePoints 
To observe adverse of shatavaryadi granules with madhu and sheeta kshira   14days study with follow up on 7th and 14th day  
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   22/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  22/07/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a single arm clinical study. The aim of this study is evaluate the efficacy of shatavaryadi granules with madhu and sheeta kshira in management of garbhini parikartika . Total 40 patients will be enrolled and 10gm shatavaryadi granules will be given with madhu and sheeta kshira twice a day after meal for 15 days. The age group taken for study is 21 to 40 years women. The final conclusion will be drawn on the the basis of statistical methods. 
Close